Company intelligence / Profile preview

Trulieve

Ownership: Private
Employees: ~6500
Development stage: Commercial

Overview

Trulieve operates a large-scale commercial business providing both medical and adult-use cannabis products. It reported $1.2 billion in sales for 2022 and holds leading market positions in several U.S. states. The company claims to focus on high-quality cultivation practices with an emphasis on patient care and product safety. No clinical trial results are available as it does not develop FDA-approved pharmaceuticals.

Therapeutic areas: OtherNeurology
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Trulieve.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trulieve.

Explore the full profile